NUMANS (02530) announced that the group expects to achieve a net profit of RMB 2 million to RMB 5 million for the six months ended June 30, 2025, compared to a net profit of approximately RMB 45.3 million for the six months ended June 30, 2024. The board of directors believes that the expected decrease in net profit is mainly due to (including): significant revenue decline caused by overall consumption downgrade in China's economy; intensified competition from domestic DHA products; and reduction in other income primarily stemming from decreased government subsidies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments